SOLICITATION NOTICE
A -- Evidence-based treatment guidelines for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - RFQ
- Notice Date
- 9/8/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 75D301-18-Q-69445
- Archive Date
- 9/28/2018
- Point of Contact
- Mary Wimer, Phone: 4046391262
- E-Mail Address
-
zmy5@cdc.gov
(zmy5@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- Combined synopsized solicitation ME CFS The development of federal guidelines is a time and labor-intensive process. The CDC ME/CFS program has been advised by CDC's Office of the Associate Director for Science (OADS) that the process typically takes 3-5 years. OADS has recommended use of existing systematic literature reviews as a strategy that can help expedite the development of federal guidelines. An existing systematic literature review, entitled "Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" (available at: https://archive.ahrq.gov/research/findings/evidence-based-reports/er219-abstract.html), will be leveraged to serve as the foundation for ME/CFS treatment guidelines development. No other comparable and recent literature review has been published. Commissioned by the Agency for Healthcare Research and Quality (AHRQ) and part of its Evidence Review/Technology Assessment series, the literature review was originally published in 2014 and was updated in 2016. The initial report provided a literature review for the National Institutes of Health Pathways to Prevention Workshop on Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Both the initial review and the update were completed by the Pacific Northwest Evidence-based Practice Center (EPC). The CDC has a requirement for updating ME/CFS treatment guidelines with recent literature and supplementing the prior review and guidelines that were recommended by the HHS CFS Advisory Committee in June, 2017. In addition, any peer-reviewed literature that could provide context to inform treatment recommendations for symptoms associated with ME/CFS warrants review and consideration. Please see the attached synopsis for more details about this requirement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/75D301-18-Q-69445/listing.html)
- Place of Performance
- Address: TBD, United States
- Record
- SN05080317-W 20180910/180908230053-30dd6fa6af05215774b9d11d01f9f6c2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |